{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:07:34Z","timestamp":1778620054129,"version":"3.51.4"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s11886-022-01741-1","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T11:02:54Z","timestamp":1657278174000},"page":"1149-1157","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["HIV and Global Cardiovascular Health"],"prefix":"10.1007","volume":"24","author":[{"given":"Anjali","family":"Wagle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Goerlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy S.","family":"Post","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bethel","family":"Woldu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine C.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison G.","family":"Hays","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,8]]},"reference":[{"key":"1741_CR1","unstructured":"CONFRONTING INEQUALITIES: Lessons for pandemic responses from 40 years of AIDS [Internet]. GLOBAL AIDS UPDATE 2021; Available from: https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2021-global-aids-update_en.pdf"},{"key":"1741_CR2","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S0140-6736(14)60844-8","volume":"384","author":"CJL Murray","year":"2014","unstructured":"Murray CJL, Ortblad KF, Guinovart C, Lim SS, Wolock TM, Roberts DA, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:1005\u201370.","journal-title":"Lancet"},{"key":"1741_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081355","volume":"8","author":"H Samji","year":"2013","unstructured":"Samji H, Cescon A, Hogg RS, Modur SP, Althoff KN, Buchacz K, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS ONE. 2013;8: e81355.","journal-title":"PLoS ONE"},{"key":"1741_CR4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1056\/NEJM199808063390612","volume":"339","author":"SH Michaels","year":"1998","unstructured":"Michaels SH, Clark R, Kissinger P. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;339:405\u20136.","journal-title":"N Engl J Med"},{"key":"1741_CR5","doi-asserted-by":"crossref","unstructured":"Schouten J, Wit FW, Stolte IG, Kootstra NA, van der Valk M, Geerlings SE, et al. Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. Clin Infect Dis. 2014;59:1787\u201397.","DOI":"10.1093\/cid\/ciu701"},{"key":"1741_CR6","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Shah ASV, Stelzle D, Lee KK, Beck EJ, Alam S, Clifford S, et al. Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV: Systematic Review and Meta-Analysis. Circulation.\u00a02018;138:1100\u201312.\u00a0Review analyzing the rate and risk of CVD in PLWH.","DOI":"10.1161\/CIRCULATIONAHA.117.033369"},{"key":"1741_CR7","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/QAI.0b013e3181a9992c","volume":"51","author":"VA Triant","year":"2009","unstructured":"Triant VA, Meigs JB, Grinspoon SK. Association of C-reactive protein and HIV infection with acute myocardial infarction. J Acquir Immune Defic Syndr. 2009;51:268\u201373.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1741_CR8","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/j.jacc.2012.02.024","volume":"59","author":"ZH Tseng","year":"2012","unstructured":"Tseng ZH, Secemsky EA, Dowdy D, Vittinghoff E, Moyers B, Wong JK, et al. Sudden cardiac death in patients with human immunodeficiency virus infection. J Am Coll Cardiol. 2012;59:1891\u20136.","journal-title":"J Am Coll Cardiol"},{"key":"1741_CR9","doi-asserted-by":"publisher","first-page":"458","DOI":"10.7326\/M13-1754","volume":"160","author":"WS Post","year":"2014","unstructured":"Post WS, Budoff M, Kingsley L, Palella FJ, Witt MD, Li X, et al. Associations between HIV infection and subclinical coronary atherosclerosis. Ann Intern Med. 2014;160:458\u201367.","journal-title":"Ann Intern Med"},{"key":"1741_CR10","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1097\/QAD.0b013e328339192f","volume":"24","author":"S Lang","year":"2010","unstructured":"Lang S, Mary-Krause M, Cotte L, Gilquin J, Partisani M, Simon A, et al. Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population. AIDS. 2010;24:1228\u201330.","journal-title":"AIDS"},{"key":"1741_CR11","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/S2213-8587(15)00388-5","volume":"4","author":"E Nou","year":"2016","unstructured":"Nou E, Lo J, Hadigan C, Grinspoon SK. Pathophysiology and management of cardiovascular disease in patients with HIV. Lancet Diabetes Endocrinol. 2016;4:598\u2013610.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1741_CR12","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S1473-3099(15)00056-0","volume":"15","author":"M Smit","year":"2015","unstructured":"Smit M, Brinkman K, Geerlings S, Smit C, Thyagarajan K, van Sighem A, et al. Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect Dis. 2015;15:810\u20138.","journal-title":"Lancet Infect Dis"},{"key":"1741_CR13","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1161\/CIRCULATIONAHA.107.189622","volume":"118","author":"SK Grinspoon","year":"2008","unstructured":"Grinspoon SK, Grunfeld C, Kotler DP, Currier JS, Lundgren JD, Dub\u00e9 MP, et al. State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV\/AIDS: executive summary. Circulation. 2008;118:198\u2013210.","journal-title":"Circulation"},{"key":"1741_CR14","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1093\/eurheartj\/ehs471","volume":"34","author":"E Cerrato","year":"2013","unstructured":"Cerrato E, D\u2019Ascenzo F, Biondi-Zoccai G, Calcagno A, Frea S, Grosso Marra W, et al. Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy era. Eur Heart J. 2013;34:1432\u20136.","journal-title":"Eur Heart J"},{"key":"1741_CR15","doi-asserted-by":"crossref","unstructured":"Sliwa K, Carrington MJ, Becker A, Thienemann F, Ntsekhe M, Stewart S. Contribution of the human immunodeficiency virus\/acquired immunodeficiency syndrome epidemic to de novo presentations of heart disease in the Heart of Soweto Study cohort. Eur Heart J. 2012;33:866\u201374.","DOI":"10.1093\/eurheartj\/ehr398"},{"key":"1741_CR16","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 So-Armah K, Benjamin LA, Bloomfield GS, Feinstein MJ, Hsue P, Njuguna B, et al. HIV and cardiovascular disease. Lancet HIV. 2020;7:e279\u201393. Review highlighting the global variation in risk factors and future research needs in HIV associated CVD.","DOI":"10.1016\/S2352-3018(20)30036-9"},{"key":"1741_CR17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3851\/IMP3298","volume":"24","author":"R Bijker","year":"2019","unstructured":"Bijker R, Kumarasamy N, Kiertiburanakul S, Pujari S, Lam W, Chaiwarith R, et al. Cardiovascular disease incidence projections in the TREAT Asia HIV Observational Database (TAHOD). Antivir Ther. 2019;24:271\u20139.","journal-title":"Antivir Ther"},{"key":"1741_CR18","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jacc.2012.06.063","volume":"61","author":"F Boccara","year":"2013","unstructured":"Boccara F, Lang S, Meuleman C, Ederhy S, Mary-Krause M, Costagliola D, et al. HIV and coronary heart disease: time for a better understanding. J Am Coll Cardiol. 2013;61:511\u201323.","journal-title":"J Am Coll Cardiol"},{"key":"1741_CR19","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2174\/1874613601711010052","volume":"11","author":"R Bijker","year":"2017","unstructured":"Bijker R, Choi JY, Ditangco R, Kiertiburanakul S, Lee MP, Siwamogsatham S, et al. Cardiovascular Disease and Cardiovascular Disease Risk in HIV-Positive Populations in the Asian Region. Open AIDS J. 2017;11:52\u201366.","journal-title":"Open AIDS J"},{"key":"1741_CR20","first-page":"261","volume":"7","author":"VV Joshi","year":"1987","unstructured":"Joshi VV, Pawel B, Connor E, Sharer L, Oleske JM, Morrison S, et al. Arteriopathy in children with acquired immune deficiency syndrome. Pediatr Pathol. 1987;7:261\u201375.","journal-title":"Pediatr Pathol"},{"key":"1741_CR21","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0923-2516(06)80033-6","volume":"144","author":"P Paton","year":"1993","unstructured":"Paton P, Tabib A, Loire R, Tete R. Coronary artery lesions and human immunodeficiency virus infection. Res Virol. 1993;144:225\u201331.","journal-title":"Res Virol"},{"key":"1741_CR22","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/nm1511","volume":"12","author":"JM Brenchley","year":"2006","unstructured":"Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12:1365\u201371.","journal-title":"Nat Med"},{"key":"1741_CR23","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1097\/JIM.0b013e3181788d15","volume":"56","author":"ER Kline","year":"2008","unstructured":"Kline ER, Sutliff RL. The roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunction. J Investig Med. 2008;56:752\u201369.","journal-title":"J Investig Med"},{"key":"1741_CR24","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"GK Hansson","year":"2005","unstructured":"Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685\u201395.","journal-title":"N Engl J Med"},{"key":"1741_CR25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1001\/archinte.166.1.64","volume":"166","author":"B Lau","year":"2006","unstructured":"Lau B, Sharrett AR, Kingsley LA, Post W, Palella FJ, Visscher B, et al. C-reactive protein is a marker for human immunodeficiency virus disease progression. Arch Intern Med. 2006;166:64\u201370.","journal-title":"Arch Intern Med"},{"key":"1741_CR26","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1086\/652749","volume":"201","author":"J Neuhaus","year":"2010","unstructured":"Neuhaus J, Jacobs DR, Baker JV, Calmy A, Duprez D, La Rosa A, et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis. 2010;201:1788\u201395.","journal-title":"J Infect Dis"},{"key":"1741_CR27","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002683","volume":"5","author":"P Kohli","year":"2016","unstructured":"Kohli P, Ganz P, Ma Y, Scherzer R, Hur S, Weigel B, et al. HIV and hepatitis C-coinfected patients have lower low-density lipoprotein cholesterol despite higher proprotein convertase subtilisin kexin 9 (PCSK9): an apparent \u201cPCSK9-lipid paradox.\u201d J Am Heart Assoc. 2016;5: e002683.","journal-title":"J Am Heart Assoc"},{"key":"1741_CR28","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1097\/QAD.0000000000001633","volume":"31","author":"F Boccara","year":"2017","unstructured":"Boccara F, Ghislain M, Meyer L, Goujard C, Le May C, Vigouroux C, et al. Impact of protease inhibitors on circulating PCSK9 levels in HIV-infected antiretroviral-naive patients from an ongoing prospective cohort. AIDS. 2017;31:2367\u201376.","journal-title":"AIDS"},{"key":"1741_CR29","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.009996","volume":"7","author":"TM Leucker","year":"2018","unstructured":"Leucker TM, Weiss RG, Sch\u00e4r M, Bonanno G, Mathews L, Jones SR, et al. Coronary endothelial dysfunction is associated with elevated serum PCSK9 levels in people with HIV independent of low-density lipoprotein cholesterol. J Am Heart Assoc. 2018;7: e009996.","journal-title":"J Am Heart Assoc"},{"key":"1741_CR30","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1097\/QAD.0b013e32832b514b","volume":"23","author":"PY Hsue","year":"2009","unstructured":"Hsue PY, Hunt PW, Schnell A, Kalapus SC, Hoh R, Ganz P, et al. Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis. AIDS. 2009;23:1059\u201367.","journal-title":"AIDS"},{"key":"1741_CR31","doi-asserted-by":"crossref","unstructured":"Strategies for Management of Antiretroviral Therapy (SMART) Study Group, El-Sadr WM, Lundgren JD, Neaton JD, Gordin F, Abrams D, et al. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006;355:2283\u201396.","DOI":"10.1056\/NEJMoa062360"},{"key":"1741_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155100","volume":"11","author":"B Grund","year":"2016","unstructured":"Grund B, Baker JV, Deeks SG, Wolfson J, Wentworth D, Cozzi-Lepri A, et al. Relevance of interleukin-6 and D-dimer for serious non-AIDS morbidity and death among HIV-positive adults on suppressive antiretroviral therapy. PLoS ONE. 2016;11: e0155100.","journal-title":"PLoS ONE"},{"key":"1741_CR33","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/0002-9343(91)80154-E","volume":"90","author":"C Grunfeld","year":"1991","unstructured":"Grunfeld C, Kotler DP, Shigenaga JK, Doerrler W, Tierney A, Wang J, et al. Circulating interferon-alpha levels and hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med. 1991;90:154\u201362.","journal-title":"Am J Med"},{"key":"1741_CR34","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/0002-9343(93)90087-6","volume":"94","author":"G Shor-Posner","year":"1993","unstructured":"Shor-Posner G, Basit A, Lu Y, Cabrejos C, Chang J, Fletcher M, et al. Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection. Am J Med. 1993;94:515\u20139.","journal-title":"Am J Med"},{"key":"1741_CR35","first-page":"1423","volume":"76","author":"KR Feingold","year":"1993","unstructured":"Feingold KR, Krauss RM, Pang M, Doerrler W, Jensen P, Grunfeld C. The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B. J Clin Endocrinol Metab. 1993;76:1423\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"1741_CR36","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1161\/ATVBAHA.112.300125","volume":"33","author":"B Enkhmaa","year":"2013","unstructured":"Enkhmaa B, Anuurad E, Zhang W, Abbuthalha A, Li X-D, Dotterweich W, et al. HIV disease activity as a modulator of lipoprotein(a) and allele-specific apolipoprotein(a) levels. Arterioscler Thromb Vasc Biol. 2013;33:387\u201392.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1741_CR37","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1001\/jama.289.22.2978","volume":"289","author":"SA Riddler","year":"2003","unstructured":"Riddler SA, Smit E, Cole SR, Li R, Chmiel JS, Dobs A, et al. Impact of HIV infection and HAART on serum lipids in men. JAMA. 2003;289:2978\u201382.","journal-title":"JAMA"},{"key":"1741_CR38","doi-asserted-by":"crossref","unstructured":"Sarkar S, Haberlen S, Whelton S, E Schneider E, Kingsley L, Palella F, et al. Greater IL-6, D-dimer, and ICAM-1 levels are associated with lower small HDL particle concentration in the multicenter AIDS cohort study. Open Forum Infect Dis. 2019;6:ofz474.","DOI":"10.1093\/ofid\/ofz474"},{"key":"1741_CR39","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1056\/NEJMoa030218","volume":"349","author":"N Friis-M\u00f8ller","year":"2003","unstructured":"Friis-M\u00f8ller N, Sabin CA, Weber R, d\u2019Arminio Monforte A, El-Sadr WM, Reiss P, et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003;349:1993\u20132003.","journal-title":"N Engl J Med"},{"key":"1741_CR40","doi-asserted-by":"crossref","unstructured":"DAD Study Group, Friis-M\u00f8ller N, Reiss P, Sabin CA, Weber R, Monforte A d\u2019Arminio, et al. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med. 2007;356:1723\u201335.","DOI":"10.1056\/NEJMoa062744"},{"key":"1741_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.635089","volume":"12","author":"VD Kajogoo","year":"2021","unstructured":"Kajogoo VD, Gorret Atim M, Amare D, Geleta M, Muchie Y, Tesfahunei HA, et al. HIV protease inhibitors and insulin sensitivity: a systematic review and meta-analysis of randomized controlled trials. Front Pharmacol. 2021;12: 635089.","journal-title":"Front Pharmacol"},{"key":"1741_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0010019","volume":"1","author":"F van Leth","year":"2004","unstructured":"van Leth F, Phanuphak P, Stroes E, Gazzard B, Cahn P, Raffi F, et al. Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral- therapy-naive patients infected with HIV-1. PLoS Med. 2004;1: e19.","journal-title":"PLoS Med"},{"key":"1741_CR43","doi-asserted-by":"publisher","first-page":"947","DOI":"10.7326\/0003-4819-127-10-199711150-00016","volume":"127","author":"F Visnegarwala","year":"1997","unstructured":"Visnegarwala F, Krause KL, Musher DM. Severe diabetes associated with protease inhibitor therapy. Ann Intern Med. 1997;127:947.","journal-title":"Ann Intern Med"},{"key":"1741_CR44","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S0140-6736(05)63513-1","volume":"350","author":"MP Dub\u00e9","year":"1997","unstructured":"Dub\u00e9 MP, Johnson DL, Currier JS, Leedom JM. Protease inhibitor-associated hyperglycaemia. Lancet. 1997;350:713\u20134.","journal-title":"Lancet"},{"key":"1741_CR45","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/S0140-6736(98)03391-1","volume":"351","author":"A Carr","year":"1998","unstructured":"Carr A, Samaras K, Chisholm DJ, Cooper DA. Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet. 1998;351:1881\u20133.","journal-title":"Lancet"},{"key":"1741_CR46","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1124\/mol.105.012898","volume":"68","author":"H Zhou","year":"2005","unstructured":"Zhou H, Pandak WM, Lyall V, Natarajan R, Hylemon PB. HIV protease inhibitors activate the unfolded protein response in macrophages: implication for atherosclerosis and cardiovascular disease. Mol Pharmacol. 2005;68:690\u2013700.","journal-title":"Mol Pharmacol"},{"key":"1741_CR47","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1074\/jbc.M506046200","volume":"281","author":"KF Allred","year":"2006","unstructured":"Allred KF, Smart EJ, Wilson ME. Estrogen receptor-alpha mediates gender differences in atherosclerosis induced by HIV protease inhibitors. J Biol Chem. 2006;281:1419\u201325.","journal-title":"J Biol Chem"},{"key":"1741_CR48","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1086\/649897","volume":"201","author":"SW Worm","year":"2010","unstructured":"Worm SW, Sabin C, Weber R, Reiss P, El-Sadr W, Dabis F, et al. Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study. J Infect Dis. 2010;201:318\u201330.","journal-title":"J Infect Dis"},{"key":"1741_CR49","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1089\/aid.2012.0234","volume":"29","author":"W Lakey","year":"2013","unstructured":"Lakey W, Yang L-Y, Yancy W, Chow S-C, Hicks C. Short communication: from wasting to obesity: initial antiretroviral therapy and weight gain in HIV-infected persons. AIDS Res Hum Retroviruses. 2013;29:435\u201340.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"1741_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010106","volume":"5","author":"N Crum-Cianflone","year":"2010","unstructured":"Crum-Cianflone N, Roediger MP, Eberly L, Headd M, Marconi V, Ganesan A, et al. Increasing rates of obesity among HIV-infected persons during the HIV epidemic. PLoS ONE. 2010;5: e10106.","journal-title":"PLoS ONE"},{"key":"1741_CR51","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1089\/aid.2015.0147","volume":"32","author":"JR Koethe","year":"2016","unstructured":"Koethe JR, Jenkins CA, Lau B, Shepherd BE, Justice AC, Tate JP, et al. Rising obesity prevalence and weight gain among adults starting antiretroviral therapy in the United States and Canada. AIDS Res Hum Retroviruses. 2016;32:50\u20138.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"1741_CR52","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11892-021-01382-8","volume":"21","author":"S Sarkar","year":"2021","unstructured":"Sarkar S, Brown TT. Diabetes in People with HIV. Curr Diab Rep. 2021;21:13.","journal-title":"Curr Diab Rep"},{"key":"1741_CR53","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.jash.2017.06.004","volume":"11","author":"Y Xu","year":"2017","unstructured":"Xu Y, Chen X, Wang K. Global prevalence of hypertension among people living with HIV: a systematic review and meta-analysis. J Am Soc Hypertens. 2017;11:530\u201340.","journal-title":"J Am Soc Hypertens"},{"key":"1741_CR54","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/COH.0000000000000407","volume":"12","author":"S Raposeiras-Roub\u00edn","year":"2017","unstructured":"Raposeiras-Roub\u00edn S, Abu-Assi E, I\u00f1iguez-Romo A. Tobacco, illicit drugs use and risk of cardiovascular disease in patients living with HIV. Curr Opin HIV AIDS. 2017;12:523\u20137.","journal-title":"Curr Opin HIV AIDS"},{"key":"1741_CR55","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/cid\/cis933","volume":"56","author":"M Helleberg","year":"2013","unstructured":"Helleberg M, Afzal S, Kronborg G, Larsen CS, Pedersen G, Pedersen C, et al. Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study. Clin Infect Dis. 2013;56:727\u201334.","journal-title":"Clin Infect Dis"},{"key":"1741_CR56","doi-asserted-by":"crossref","unstructured":"Nduka CU, Uthman OA. Drug abuse in people living with HIV in the era of highly active antiretroviral therapy: a systematic review and meta-analysis. J Addict Res Ther [Internet]. 2015 [cited 2022 Apr 10];06. Available from: https:\/\/www.omicsonline.org\/open-access\/drug-abuse-in-people-living-with-hiv-in-the-era-of-highly-active-antiretroviral-therapy-a-systematic-review-and-metaanalysis-2155-6105-1000255.php?aid=66245","DOI":"10.4172\/2155-6105.1000255"},{"key":"1741_CR57","doi-asserted-by":"crossref","unstructured":"Doria de Vasconcellos H, Post WS, Ervin A-M, Haberlen SA, Budoff M, Malvestutto C, et al. Associations between HIV serostatus and cardiac structure and function evaluated by 2-dimensional echocardiography in the multicenter AIDS cohort study. J Am Heart Assoc. 2021;10:e019709.","DOI":"10.1161\/JAHA.120.019709"},{"key":"1741_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244742","volume":"16","author":"GVT Roozen","year":"2021","unstructured":"Roozen GVT, Meel R, Peper J, Venter WDF, Barth RE, Grobbee DE, et al. Electrocardiographic and echocardiographic abnormalities in urban African people living with HIV in South Africa. PLoS ONE. 2021;16: e0244742.","journal-title":"PLoS ONE"},{"key":"1741_CR59","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2021-001814","volume":"9","author":"B Woldu","year":"2022","unstructured":"Woldu B, Temu TM, Kirui N, Christopher B, Ndege S, Post WS, et al. Diastolic dysfunction in people with HIV without known cardiovascular risk factors in Western Kenya. Open Heart. 2022;9: e001814.","journal-title":"Open Heart"},{"key":"1741_CR60","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.echo.2019.12.010","volume":"33","author":"S Mahtab","year":"2020","unstructured":"Mahtab S, Lawrenson J, Jamieson-Luff N, Asafu-Agyei NA, Meiring A, Lemmer-Hunsinger C, et al. Echocardiographic findings in a cohort of perinatally HIV-infected adolescents compared with uninfected peers from the Cape Town adolescent antiretroviral cohort. J Am Soc Echocardiogr. 2020;33:604\u201311.","journal-title":"J Am Soc Echocardiogr"},{"key":"1741_CR61","doi-asserted-by":"publisher","first-page":"e417","DOI":"10.1016\/S2666-7568(21)00116-1","volume":"2","author":"MS Duncan","year":"2021","unstructured":"Duncan MS, Alcorn CW, Freiberg MS, So-Armah K, Patterson OV, DuVall SL, et al. Association between HIV and incident pulmonary hypertension in US Veterans: a retrospective cohort study. Lancet Healthy Longev. 2021;2:e417\u201325.","journal-title":"Lancet Healthy Longev"},{"key":"1741_CR62","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1161\/CIRCULATIONAHA.113.001719","volume":"128","author":"CJ Holloway","year":"2013","unstructured":"Holloway CJ, Ntusi N, Suttie J, Mahmod M, Wainwright E, Clutton G, et al. Comprehensive cardiac magnetic resonance imaging and spectroscopy reveal a high burden of myocardial disease in HIV patients. Circulation. 2013;128:814\u201322.","journal-title":"Circulation"},{"key":"1741_CR63","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.115.004430","volume":"9","author":"N Ntusi","year":"2016","unstructured":"Ntusi N, O\u2019Dwyer E, Dorrell L, Wainwright E, Piechnik S, Clutton G, et al. HIV-1-related cardiovascular disease is associated with chronic inflammation, frequent pericardial effusions, and probable myocardial edema. Circ Cardiovasc Imaging. 2016;9: e004430.","journal-title":"Circ Cardiovasc Imaging"},{"key":"1741_CR64","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1093\/infdis\/jiv274","volume":"212","author":"DK Thiara","year":"2015","unstructured":"Thiara DK, Liu CY, Raman F, Mangat S, Purdy JB, Duarte HA, et al. Abnormal myocardial function is related to myocardial steatosis and diffuse myocardial fibrosis in HIV-infected adults. J Infect Dis. 2015;212:1544\u201351.","journal-title":"J Infect Dis"},{"key":"1741_CR65","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1016\/j.jcmg.2021.01.042","volume":"14","author":"P de Leuw","year":"2021","unstructured":"de Leuw P, Arendt CT, Haberl AE, Froadinadl D, Kann G, Wolf T, et al. Myocardial fibrosis and inflammation by CMR predict cardiovascular outcome in people living with HIV. JACC Cardiovasc Imaging. 2021;14:1548\u201357.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1741_CR66","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1093\/infdis\/jiaa245","volume":"222","author":"TG Neilan","year":"2020","unstructured":"Neilan TG, Nguyen K-L, Zaha VG, Chew KW, Morrison L, Ntusi NAB, et al. Myocardial steatosis among antiretroviral therapy-treated people with human immunodeficiency virus participating in the REPRIEVE trial. J Infect Dis. 2020;222:S63\u20139.","journal-title":"J Infect Dis"},{"key":"1741_CR67","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1093\/ehjci\/jeab037","volume":"22","author":"KC Wu","year":"2021","unstructured":"Wu KC, Haberlen SA, Plankey MW, Palella FJ, Piggott DA, Kirk GD, et al. Human immunodeficiency viral infection and differences in interstitial ventricular fibrosis and left atrial size. Eur Heart J Cardiovasc Imaging. 2021;22:888\u201395.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1741_CR68","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/QAD.0b013e328333ea9e","volume":"24","author":"J Lo","year":"2010","unstructured":"Lo J, Abbara S, Shturman L, Soni A, Wei J, Rocha-Filho JA, et al. Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men. AIDS. 2010;24:243\u201353.","journal-title":"AIDS"},{"key":"1741_CR69","doi-asserted-by":"crossref","unstructured":"Post WS, Budoff M, Kingsley L, Palella FJ, Witt MD, Li X, et al. Associations between HIV infection and subclinical coronary atherosclerosis. Ann Intern Med. American College of Physicians; 2014;160:458\u201367.","DOI":"10.7326\/M13-1754"},{"key":"1741_CR70","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1097\/QAD.0000000000000847","volume":"29","author":"LA Kingsley","year":"2015","unstructured":"Kingsley LA, Deal J, Jacobson L, Budoff M, Witt M, Palella F, et al. Incidence and progression of coronary artery calcium in HIV-infected and HIV-uninfected men. AIDS. 2015;29:2427\u201334.","journal-title":"AIDS"},{"key":"1741_CR71","unstructured":"Post W, Haberlen HS, Witt MD, Zhang Long, Jacobson LP, Brown TT, et al. Suboptimal HIV suppression is associated with progression of coronary artery stenosis: the multicenter AIDS cohort study (MACS) longitudinal coronary CT angiography study. AIDS (London, England)."},{"key":"1741_CR72","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1136\/heartjnl-2016-309752","volume":"102","author":"MJ Feinstein","year":"2016","unstructured":"Feinstein MJ. Cardiovascular disease risk assessment in HIV: navigating data-sparse zones. Heart. 2016;102:1157\u20138.","journal-title":"Heart"},{"key":"1741_CR73","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1161\/CIRCULATIONAHA.118.036211","volume":"138","author":"PY Hsue","year":"2018","unstructured":"Hsue PY, Waters DD. Time to recognize HIV infection as a major cardiovascular risk factor. Circulation. 2018;138:1113\u20135.","journal-title":"Circulation"},{"key":"1741_CR74","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1161\/CIR.0000000000000695","volume":"140","author":"MJ Feinstein","year":"2019","unstructured":"Feinstein MJ, Hsue PY, Benjamin LA, Bloomfield GS, Currier JS, Freiberg MS, et al. Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the American Heart Association. Circulation. 2019;140:e98-124.","journal-title":"Circulation"},{"key":"1741_CR75","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1161\/CIRCULATIONAHA.117.028975","volume":"137","author":"VA Triant","year":"2018","unstructured":"Triant VA, Perez J, Regan S, Massaro JM, Meigs JB, Grinspoon SK, et al. Cardiovascular risk prediction functions underestimate risk in HIV infection. Circulation. 2018;137:2203\u201314.","journal-title":"Circulation"},{"key":"1741_CR76","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","volume":"97","author":"PW Wilson","year":"1998","unstructured":"Wilson PW, D\u2019Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837\u201347.","journal-title":"Circulation"},{"key":"1741_CR77","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1177\/2047487315579291","volume":"23","author":"N Friis-M\u00f8ller","year":"2016","unstructured":"Friis-M\u00f8ller N, Ryom L, Smith C, Weber R, Reiss P, Dabis F, et al. An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: the data-collection on adverse effects of anti-HIV drugs (D:A:D) study. Eur J Prev Cardiol. 2016;23:214\u201323.","journal-title":"Eur J Prev Cardiol"},{"key":"1741_CR78","doi-asserted-by":"crossref","unstructured":"Ryom L, Cotter A, De Miguel R, B\u00e9guelin C, Podlekareva D, Arribas JR, et al. 2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0. HIV Med. 2020;21:617\u201324.","DOI":"10.1111\/hiv.12878"},{"key":"1741_CR79","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/jcph.473","volume":"55","author":"M Myerson","year":"2015","unstructured":"Myerson M, Malvestutto C, Aberg JA. Management of lipid disorders in patients living with HIV. J Clin Pharmacol. 2015;55:957\u201374.","journal-title":"J Clin Pharmacol"},{"key":"1741_CR80","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.pcad.2020.02.004","volume":"63","author":"S Okello","year":"2020","unstructured":"Okello S, Amir A, Bloomfield GS, Kentoffio K, Lugobe HM, Reynolds Z, et al. Prevention of cardiovascular disease among people living with HIV in sub-Saharan Africa. Prog Cardiovasc Dis. 2020;63:149\u201359.","journal-title":"Prog Cardiovasc Dis"},{"key":"1741_CR81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212296","volume":"14","author":"T Ojo","year":"2019","unstructured":"Ojo T, Lester L, Iwelunmor J, Gyamfi J, Obiezu-Umeh C, Onakomaiya D, et al. Feasibility of integrated, multilevel care for cardiovascular diseases (CVD) and HIV in low- and middle-income countries (LMICs): A scoping review. PLoS ONE. 2019;14: e0212296.","journal-title":"PLoS ONE"},{"key":"1741_CR82","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1093\/cid\/ciab552","volume":"73","author":"PS Douglas","year":"2021","unstructured":"Douglas PS, Umbleja T, Bloomfield GS, Fichtenbaum CJ, Zanni MV, Overton ET, et al. Cardiovascular risk and health among people with human immunodeficiency Virus (HIV) eligible for primary prevention: insights from the REPRIEVE Trial. Clin Infect Dis. 2021;73:2009\u201322.","journal-title":"Clin Infect Dis"},{"key":"1741_CR83","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1093\/cid\/ciy781","volume":"68","author":"PY Hsue","year":"2019","unstructured":"Hsue PY, Ribaudo HJ, Deeks SG, Bell T, Ridker PM, Fichtenbaum C, et al. Safety and impact of low-dose methotrexate on endothelial function and inflammation in individuals with treated human immunodeficiency virus: AIDS Clinical Trials Group Study A5314. Clin Infect Dis. 2019;68:1877\u201386.","journal-title":"Clin Infect Dis"},{"key":"1741_CR84","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1097\/QAD.0000000000002845","volume":"35","author":"AG Hays","year":"2021","unstructured":"Hays AG, Sch\u00e4r M, Barditch-Crovo P, Bagchi S, Bonanno G, Meyer J, et al. A randomized, placebo-controlled, double-blinded clinical trial of colchicine to improve vascular health in people living with HIV. AIDS. 2021;35:1041\u201350.","journal-title":"AIDS"},{"key":"1741_CR85","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1016\/j.jacc.2018.09.038","volume":"72","author":"PY Hsue","year":"2018","unstructured":"Hsue PY, Li D, Ma Y, Ishai A, Manion M, Nahrendorf M, et al. IL-1\u03b2 inhibition reduces atherosclerotic inflammation in HIV infection. J Am Coll Cardiol. 2018;72:2809\u201311.","journal-title":"J Am Coll Cardiol"},{"key":"1741_CR86","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.016263","volume":"9","author":"TM Leucker","year":"2020","unstructured":"Leucker TM, Gerstenblith G, Sch\u00e4r M, Brown TT, Jones SR, Afework Y, et al. Evolocumab, a PCSK9-monoclonal antibody, rapidly reverses coronary artery endothelial dysfunction in people living with HIV and people with dyslipidemia. J Am Heart Assoc. 2020;9: e016263.","journal-title":"J Am Heart Assoc"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-022-01741-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-022-01741-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-022-01741-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T12:08:10Z","timestamp":1660565290000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-022-01741-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,8]]},"references-count":86,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["1741"],"URL":"https:\/\/doi.org\/10.1007\/s11886-022-01741-1","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,8]]},"assertion":[{"value":"19 June 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}